Point-of-Care Testing (POCT) Industry Research Report 2024
Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
According to APO Research, the global Point-of-Care Testing (POCT) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point-of-Care Testing (POCT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-Care Testing (POCT).
The report will help the Point-of-Care Testing (POCT) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Point-of-Care Testing (POCT) market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point-of-Care Testing (POCT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Point-of-Care Testing (POCT) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Point-of-Care Testing (POCT) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Point-of-Care Testing (POCT) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point-of-Care Testing (POCT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-Care Testing (POCT).
The report will help the Point-of-Care Testing (POCT) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Point-of-Care Testing (POCT) market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point-of-Care Testing (POCT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Roche
- Abbott
- Johnson & Johnson
- Siemens Healthcare
- Danaher
- Ascensia
- Bio-Rad Laboratories
- BioMerieux
- ARKRAY
- Nova Biomedical
- Trividia Health
- Quidel
- Accriva
- OraSure Technologies
- Helena Laboratories
- A. Menarini Diagnostics
- Abaxis (Zoetis)
- Ortho Clinical Diagnostics
- Phamatech
- Chembio Diagnostics
- Trinity Biotech
- ELITech Group
- Response Biomedical
- Princeton BioMeditech
- Alfa Wassermann
- Blood Glucose Testing
- Infectious Diseases Testing
- Cardiac Markers Testing
- Coagulation Testing
- Pregnancy and Fertility Testing
- Blood Gas/Electrolytes Testing
- Urinalysis Testing
- Clinics
- Hospitals
- Laboratory
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Point-of-Care Testing (POCT) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Point-of-Care Testing (POCT) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Point-of-Care Testing (POCT) Market Size (2019-2030) & (US$ Million)
2.2.2 Global Point-of-Care Testing (POCT) Sales (2019-2030)
2.2.3 Global Point-of-Care Testing (POCT) Market Average Price (2019-2030)
2.3 Point-of-Care Testing (POCT) by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Blood Glucose Testing
2.3.3 Infectious Diseases Testing
2.3.4 Cardiac Markers Testing
2.3.5 Coagulation Testing
2.3.6 Pregnancy and Fertility Testing
2.3.7 Blood Gas/Electrolytes Testing
2.3.8 Urinalysis Testing
2.4 Point-of-Care Testing (POCT) by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Clinics
2.4.3 Hospitals
2.4.4 Laboratory
2.4.5 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Point-of-Care Testing (POCT) Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Point-of-Care Testing (POCT) Sales (M Units) of Manufacturers (2019-2024)
3.3 Global Point-of-Care Testing (POCT) Revenue of Manufacturers (2019-2024)
3.4 Global Point-of-Care Testing (POCT) Average Price by Manufacturers (2019-2024)
3.5 Global Point-of-Care Testing (POCT) Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Point-of-Care Testing (POCT), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Point-of-Care Testing (POCT), Product Type & Application
3.8 Global Manufacturers of Point-of-Care Testing (POCT), Date of Enter into This Industry
3.9 Global Point-of-Care Testing (POCT) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Roche
4.1.1 Roche Company Information
4.1.2 Roche Business Overview
4.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
4.1.5 Roche Recent Developments
4.2 Abbott
4.2.1 Abbott Company Information
4.2.2 Abbott Business Overview
4.2.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
4.2.5 Abbott Recent Developments
4.3 Johnson & Johnson
4.3.1 Johnson & Johnson Company Information
4.3.2 Johnson & Johnson Business Overview
4.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
4.3.5 Johnson & Johnson Recent Developments
4.4 Siemens Healthcare
4.4.1 Siemens Healthcare Company Information
4.4.2 Siemens Healthcare Business Overview
4.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
4.4.5 Siemens Healthcare Recent Developments
4.5 Danaher
4.5.1 Danaher Company Information
4.5.2 Danaher Business Overview
4.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
4.5.5 Danaher Recent Developments
4.6 Ascensia
4.6.1 Ascensia Company Information
4.6.2 Ascensia Business Overview
4.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
4.6.5 Ascensia Recent Developments
4.7 Bio-Rad Laboratories
4.7.1 Bio-Rad Laboratories Company Information
4.7.2 Bio-Rad Laboratories Business Overview
4.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
4.7.5 Bio-Rad Laboratories Recent Developments
4.8 BioMerieux
4.8.1 BioMerieux Company Information
4.8.2 BioMerieux Business Overview
4.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
4.8.5 BioMerieux Recent Developments
4.9 ARKRAY
4.9.1 ARKRAY Company Information
4.9.2 ARKRAY Business Overview
4.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
4.9.5 ARKRAY Recent Developments
4.10 Nova Biomedical
4.10.1 Nova Biomedical Company Information
4.10.2 Nova Biomedical Business Overview
4.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
4.10.5 Nova Biomedical Recent Developments
4.11 Trividia Health
4.11.1 Trividia Health Company Information
4.11.2 Trividia Health Business Overview
4.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
4.11.5 Trividia Health Recent Developments
4.12 Quidel
4.12.1 Quidel Company Information
4.12.2 Quidel Business Overview
4.12.3 Quidel Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
4.12.5 Quidel Recent Developments
4.13 Accriva
4.13.1 Accriva Company Information
4.13.2 Accriva Business Overview
4.13.3 Accriva Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
4.13.5 Accriva Recent Developments
4.14 OraSure Technologies
4.14.1 OraSure Technologies Company Information
4.14.2 OraSure Technologies Business Overview
4.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
4.14.5 OraSure Technologies Recent Developments
4.15 Helena Laboratories
4.15.1 Helena Laboratories Company Information
4.15.2 Helena Laboratories Business Overview
4.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
4.15.5 Helena Laboratories Recent Developments
4.16 A. Menarini Diagnostics
4.16.1 A. Menarini Diagnostics Company Information
4.16.2 A. Menarini Diagnostics Business Overview
4.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
4.16.5 A. Menarini Diagnostics Recent Developments
4.17 Abaxis (Zoetis)
4.17.1 Abaxis (Zoetis) Company Information
4.17.2 Abaxis (Zoetis) Business Overview
4.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
4.17.5 Abaxis (Zoetis) Recent Developments
4.18 Ortho Clinical Diagnostics
4.18.1 Ortho Clinical Diagnostics Company Information
4.18.2 Ortho Clinical Diagnostics Business Overview
4.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
4.18.5 Ortho Clinical Diagnostics Recent Developments
4.19 Phamatech
4.19.1 Phamatech Company Information
4.19.2 Phamatech Business Overview
4.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
4.19.5 Phamatech Recent Developments
4.20 Chembio Diagnostics
4.20.1 Chembio Diagnostics Company Information
4.20.2 Chembio Diagnostics Business Overview
4.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
4.20.5 Chembio Diagnostics Recent Developments
4.21 Trinity Biotech
4.21.1 Trinity Biotech Company Information
4.21.2 Trinity Biotech Business Overview
4.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
4.21.5 Trinity Biotech Recent Developments
4.22 ELITech Group
4.22.1 ELITech Group Company Information
4.22.2 ELITech Group Business Overview
4.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
4.22.5 ELITech Group Recent Developments
4.23 Response Biomedical
4.23.1 Response Biomedical Company Information
4.23.2 Response Biomedical Business Overview
4.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
4.23.5 Response Biomedical Recent Developments
4.24 Princeton BioMeditech
4.24.1 Princeton BioMeditech Company Information
4.24.2 Princeton BioMeditech Business Overview
4.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
4.24.5 Princeton BioMeditech Recent Developments
4.25 Alfa Wassermann
4.25.1 Alfa Wassermann Company Information
4.25.2 Alfa Wassermann Business Overview
4.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
4.25.5 Alfa Wassermann Recent Developments
5 GLOBAL POINT-OF-CARE TESTING (POCT) MARKET SCENARIO BY REGION
5.1 Global Point-of-Care Testing (POCT) Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Point-of-Care Testing (POCT) Sales by Region: 2019-2030
5.2.1 Global Point-of-Care Testing (POCT) Sales by Region: 2019-2024
5.2.2 Global Point-of-Care Testing (POCT) Sales by Region: 2025-2030
5.3 Global Point-of-Care Testing (POCT) Revenue by Region: 2019-2030
5.3.1 Global Point-of-Care Testing (POCT) Revenue by Region: 2019-2024
5.3.2 Global Point-of-Care Testing (POCT) Revenue by Region: 2025-2030
5.4 North America Point-of-Care Testing (POCT) Market Facts & Figures by Country
5.4.1 North America Point-of-Care Testing (POCT) Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Point-of-Care Testing (POCT) Sales by Country (2019-2030)
5.4.3 North America Point-of-Care Testing (POCT) Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Point-of-Care Testing (POCT) Market Facts & Figures by Country
5.5.1 Europe Point-of-Care Testing (POCT) Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Point-of-Care Testing (POCT) Sales by Country (2019-2030)
5.5.3 Europe Point-of-Care Testing (POCT) Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Point-of-Care Testing (POCT) Market Facts & Figures by Country
5.6.1 Asia Pacific Point-of-Care Testing (POCT) Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Point-of-Care Testing (POCT) Sales by Country (2019-2030)
5.6.3 Asia Pacific Point-of-Care Testing (POCT) Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Point-of-Care Testing (POCT) Market Facts & Figures by Country
5.7.1 Latin America Point-of-Care Testing (POCT) Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Point-of-Care Testing (POCT) Sales by Country (2019-2030)
5.7.3 Latin America Point-of-Care Testing (POCT) Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Point-of-Care Testing (POCT) Market Facts & Figures by Country
5.8.1 Middle East and Africa Point-of-Care Testing (POCT) Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2019-2030)
5.8.3 Middle East and Africa Point-of-Care Testing (POCT) Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Point-of-Care Testing (POCT) Sales by Type (2019-2030)
6.1.1 Global Point-of-Care Testing (POCT) Sales by Type (2019-2030) & (M Units)
6.1.2 Global Point-of-Care Testing (POCT) Sales Market Share by Type (2019-2030)
6.2 Global Point-of-Care Testing (POCT) Revenue by Type (2019-2030)
6.2.1 Global Point-of-Care Testing (POCT) Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2019-2030)
6.3 Global Point-of-Care Testing (POCT) Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Point-of-Care Testing (POCT) Sales by Application (2019-2030)
7.1.1 Global Point-of-Care Testing (POCT) Sales by Application (2019-2030) & (M Units)
7.1.2 Global Point-of-Care Testing (POCT) Sales Market Share by Application (2019-2030)
7.2 Global Point-of-Care Testing (POCT) Revenue by Application (2019-2030)
7.2.1 Global Point-of-Care Testing (POCT) Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2019-2030)
7.3 Global Point-of-Care Testing (POCT) Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Point-of-Care Testing (POCT) Value Chain Analysis
8.1.1 Point-of-Care Testing (POCT) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Point-of-Care Testing (POCT) Production Mode & Process
8.2 Point-of-Care Testing (POCT) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Point-of-Care Testing (POCT) Distributors
8.2.3 Point-of-Care Testing (POCT) Customers
9 GLOBAL POINT-OF-CARE TESTING (POCT) ANALYZING MARKET DYNAMICS
9.1 Point-of-Care Testing (POCT) Industry Trends
9.2 Point-of-Care Testing (POCT) Industry Drivers
9.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
9.4 Point-of-Care Testing (POCT) Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Point-of-Care Testing (POCT) Market Size (2019-2030) & (US$ Million)
2.2.2 Global Point-of-Care Testing (POCT) Sales (2019-2030)
2.2.3 Global Point-of-Care Testing (POCT) Market Average Price (2019-2030)
2.3 Point-of-Care Testing (POCT) by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Blood Glucose Testing
2.3.3 Infectious Diseases Testing
2.3.4 Cardiac Markers Testing
2.3.5 Coagulation Testing
2.3.6 Pregnancy and Fertility Testing
2.3.7 Blood Gas/Electrolytes Testing
2.3.8 Urinalysis Testing
2.4 Point-of-Care Testing (POCT) by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Clinics
2.4.3 Hospitals
2.4.4 Laboratory
2.4.5 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Point-of-Care Testing (POCT) Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Point-of-Care Testing (POCT) Sales (M Units) of Manufacturers (2019-2024)
3.3 Global Point-of-Care Testing (POCT) Revenue of Manufacturers (2019-2024)
3.4 Global Point-of-Care Testing (POCT) Average Price by Manufacturers (2019-2024)
3.5 Global Point-of-Care Testing (POCT) Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Point-of-Care Testing (POCT), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Point-of-Care Testing (POCT), Product Type & Application
3.8 Global Manufacturers of Point-of-Care Testing (POCT), Date of Enter into This Industry
3.9 Global Point-of-Care Testing (POCT) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Roche
4.1.1 Roche Company Information
4.1.2 Roche Business Overview
4.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
4.1.5 Roche Recent Developments
4.2 Abbott
4.2.1 Abbott Company Information
4.2.2 Abbott Business Overview
4.2.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
4.2.5 Abbott Recent Developments
4.3 Johnson & Johnson
4.3.1 Johnson & Johnson Company Information
4.3.2 Johnson & Johnson Business Overview
4.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
4.3.5 Johnson & Johnson Recent Developments
4.4 Siemens Healthcare
4.4.1 Siemens Healthcare Company Information
4.4.2 Siemens Healthcare Business Overview
4.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
4.4.5 Siemens Healthcare Recent Developments
4.5 Danaher
4.5.1 Danaher Company Information
4.5.2 Danaher Business Overview
4.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
4.5.5 Danaher Recent Developments
4.6 Ascensia
4.6.1 Ascensia Company Information
4.6.2 Ascensia Business Overview
4.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
4.6.5 Ascensia Recent Developments
4.7 Bio-Rad Laboratories
4.7.1 Bio-Rad Laboratories Company Information
4.7.2 Bio-Rad Laboratories Business Overview
4.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
4.7.5 Bio-Rad Laboratories Recent Developments
4.8 BioMerieux
4.8.1 BioMerieux Company Information
4.8.2 BioMerieux Business Overview
4.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
4.8.5 BioMerieux Recent Developments
4.9 ARKRAY
4.9.1 ARKRAY Company Information
4.9.2 ARKRAY Business Overview
4.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
4.9.5 ARKRAY Recent Developments
4.10 Nova Biomedical
4.10.1 Nova Biomedical Company Information
4.10.2 Nova Biomedical Business Overview
4.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
4.10.5 Nova Biomedical Recent Developments
4.11 Trividia Health
4.11.1 Trividia Health Company Information
4.11.2 Trividia Health Business Overview
4.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
4.11.5 Trividia Health Recent Developments
4.12 Quidel
4.12.1 Quidel Company Information
4.12.2 Quidel Business Overview
4.12.3 Quidel Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
4.12.5 Quidel Recent Developments
4.13 Accriva
4.13.1 Accriva Company Information
4.13.2 Accriva Business Overview
4.13.3 Accriva Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
4.13.5 Accriva Recent Developments
4.14 OraSure Technologies
4.14.1 OraSure Technologies Company Information
4.14.2 OraSure Technologies Business Overview
4.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
4.14.5 OraSure Technologies Recent Developments
4.15 Helena Laboratories
4.15.1 Helena Laboratories Company Information
4.15.2 Helena Laboratories Business Overview
4.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
4.15.5 Helena Laboratories Recent Developments
4.16 A. Menarini Diagnostics
4.16.1 A. Menarini Diagnostics Company Information
4.16.2 A. Menarini Diagnostics Business Overview
4.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
4.16.5 A. Menarini Diagnostics Recent Developments
4.17 Abaxis (Zoetis)
4.17.1 Abaxis (Zoetis) Company Information
4.17.2 Abaxis (Zoetis) Business Overview
4.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
4.17.5 Abaxis (Zoetis) Recent Developments
4.18 Ortho Clinical Diagnostics
4.18.1 Ortho Clinical Diagnostics Company Information
4.18.2 Ortho Clinical Diagnostics Business Overview
4.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
4.18.5 Ortho Clinical Diagnostics Recent Developments
4.19 Phamatech
4.19.1 Phamatech Company Information
4.19.2 Phamatech Business Overview
4.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
4.19.5 Phamatech Recent Developments
4.20 Chembio Diagnostics
4.20.1 Chembio Diagnostics Company Information
4.20.2 Chembio Diagnostics Business Overview
4.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
4.20.5 Chembio Diagnostics Recent Developments
4.21 Trinity Biotech
4.21.1 Trinity Biotech Company Information
4.21.2 Trinity Biotech Business Overview
4.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
4.21.5 Trinity Biotech Recent Developments
4.22 ELITech Group
4.22.1 ELITech Group Company Information
4.22.2 ELITech Group Business Overview
4.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
4.22.5 ELITech Group Recent Developments
4.23 Response Biomedical
4.23.1 Response Biomedical Company Information
4.23.2 Response Biomedical Business Overview
4.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
4.23.5 Response Biomedical Recent Developments
4.24 Princeton BioMeditech
4.24.1 Princeton BioMeditech Company Information
4.24.2 Princeton BioMeditech Business Overview
4.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
4.24.5 Princeton BioMeditech Recent Developments
4.25 Alfa Wassermann
4.25.1 Alfa Wassermann Company Information
4.25.2 Alfa Wassermann Business Overview
4.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
4.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
4.25.5 Alfa Wassermann Recent Developments
5 GLOBAL POINT-OF-CARE TESTING (POCT) MARKET SCENARIO BY REGION
5.1 Global Point-of-Care Testing (POCT) Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Point-of-Care Testing (POCT) Sales by Region: 2019-2030
5.2.1 Global Point-of-Care Testing (POCT) Sales by Region: 2019-2024
5.2.2 Global Point-of-Care Testing (POCT) Sales by Region: 2025-2030
5.3 Global Point-of-Care Testing (POCT) Revenue by Region: 2019-2030
5.3.1 Global Point-of-Care Testing (POCT) Revenue by Region: 2019-2024
5.3.2 Global Point-of-Care Testing (POCT) Revenue by Region: 2025-2030
5.4 North America Point-of-Care Testing (POCT) Market Facts & Figures by Country
5.4.1 North America Point-of-Care Testing (POCT) Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Point-of-Care Testing (POCT) Sales by Country (2019-2030)
5.4.3 North America Point-of-Care Testing (POCT) Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Point-of-Care Testing (POCT) Market Facts & Figures by Country
5.5.1 Europe Point-of-Care Testing (POCT) Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Point-of-Care Testing (POCT) Sales by Country (2019-2030)
5.5.3 Europe Point-of-Care Testing (POCT) Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Point-of-Care Testing (POCT) Market Facts & Figures by Country
5.6.1 Asia Pacific Point-of-Care Testing (POCT) Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Point-of-Care Testing (POCT) Sales by Country (2019-2030)
5.6.3 Asia Pacific Point-of-Care Testing (POCT) Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Point-of-Care Testing (POCT) Market Facts & Figures by Country
5.7.1 Latin America Point-of-Care Testing (POCT) Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Point-of-Care Testing (POCT) Sales by Country (2019-2030)
5.7.3 Latin America Point-of-Care Testing (POCT) Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Point-of-Care Testing (POCT) Market Facts & Figures by Country
5.8.1 Middle East and Africa Point-of-Care Testing (POCT) Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2019-2030)
5.8.3 Middle East and Africa Point-of-Care Testing (POCT) Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Point-of-Care Testing (POCT) Sales by Type (2019-2030)
6.1.1 Global Point-of-Care Testing (POCT) Sales by Type (2019-2030) & (M Units)
6.1.2 Global Point-of-Care Testing (POCT) Sales Market Share by Type (2019-2030)
6.2 Global Point-of-Care Testing (POCT) Revenue by Type (2019-2030)
6.2.1 Global Point-of-Care Testing (POCT) Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2019-2030)
6.3 Global Point-of-Care Testing (POCT) Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Point-of-Care Testing (POCT) Sales by Application (2019-2030)
7.1.1 Global Point-of-Care Testing (POCT) Sales by Application (2019-2030) & (M Units)
7.1.2 Global Point-of-Care Testing (POCT) Sales Market Share by Application (2019-2030)
7.2 Global Point-of-Care Testing (POCT) Revenue by Application (2019-2030)
7.2.1 Global Point-of-Care Testing (POCT) Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2019-2030)
7.3 Global Point-of-Care Testing (POCT) Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Point-of-Care Testing (POCT) Value Chain Analysis
8.1.1 Point-of-Care Testing (POCT) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Point-of-Care Testing (POCT) Production Mode & Process
8.2 Point-of-Care Testing (POCT) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Point-of-Care Testing (POCT) Distributors
8.2.3 Point-of-Care Testing (POCT) Customers
9 GLOBAL POINT-OF-CARE TESTING (POCT) ANALYZING MARKET DYNAMICS
9.1 Point-of-Care Testing (POCT) Industry Trends
9.2 Point-of-Care Testing (POCT) Industry Drivers
9.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
9.4 Point-of-Care Testing (POCT) Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
